GLIS2 and autosomal dominant polycystic kidney disease: Overall, the studies presented validate a paradigm for in vivo translatome discovery in ADPKD preclinical models and show that upregulation of Glis2 discovered by this approach is a marker for polycystin function both in vivo and in vitro.